Corbus Pharmaceuticals Holdings, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| RenTech | quant | 347.0K | $3.26M | 0.01% | Trimmed-2.1% | 2026-03-31 |
| StateStreet | passive | 68.9K | $646.71K | 0.00% | Added+25.0% | 2026-03-31 |
| Citadel | multi-strat | 51.3K | $481.67K | 0.00% | Trimmed-31.7% | 2026-03-31 |
| DEShaw | quant | 26.5K | $248.59K | 0.00% | Trimmed-8.1% | 2026-03-31 |
| FidelityFMR | fundamental | 688 | $6.46K | 0.00% | Trimmed-39.1% | 2026-03-31 |
| TRowePrice | fundamental | 12.6K | $119 | 0.00% | Unchanged | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-11upcoming | -1.24 | — | — |
| 2026-05-12 | -1.22 | -1.23 | -0.82% |
| 2026-03-09 | -1.58 | -1.25 | +20.69% |
| 2025-11-12 | -1.71 | -1.90 | -11.31% |
| 2025-08-05 | -1.33 | -1.44 | -8.36% |
| 2025-05-06 | -1.07 | -1.39 | -29.56% |
| 2025-03-11 | -1.26 | -0.78 | +38.04% |
| 2024-11-07 | -0.95 | -1.15 | -20.73% |
| 2024-08-06 | -1.19 | -0.90 | +24.26% |
| 2024-05-07 | -1.09 | -0.83 | +23.85% |
| 2024-03-12 | -2.36 | -1.81 | +23.31% |
| 2023-11-07 | -2.06 | -2.27 | -10.19% |
| 2023-08-08 | -3.10 | -2.05 | +33.87% |
| 2023-05-09 | -4.09 | -4.24 | -3.67% |
| 2023-03-07 | -2.10 | -2.61 | -24.29% |
| 2022-11-08 | -1.65 | -2.10 | -27.27% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| CRBP | -23.20% | -3.65% | -2.83% | +6.60% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -26.17% | +0.98% | +0.62% | -6.08% |